Explore our

For over a century, the life sciences industry has relied on animal models as the standard for predicting drug safety and effect. But today, the industry faces a harsh reality: over 90% of new drugs that appear safe and effective in animal tests ultimately fail in human clinical trials (see for example Ineichen et al. 2024 [1] and Marshall et al. 2023[2])

Oncology drug development often begins in patients, allowing early safety and efficacy insights. Yet many cancer drugs still fail in the clinic. We validate the target but ignore its context within the tumor microenvironment. This article explores why spatial biology may improve clinical success.

Bioinformatics pipelines break for the smallest reasons: package updates, shifting dependencies, or “it only works on my machine.” This post explains why experienced software engineers and DevOps practices (Git, CI/CD, IaC) are essential to keep workflows reproducible, stable, and scalable.

Modern biomarker discovery relies on multi-omics and AI/ML to uncover complex disease patterns. BioLizard’s Bio|Mx empowers researchers to integrate diverse datasets, generate actionable insights, and drive biology-focused, data-driven R&D in human health.

Biomarker discovery enables safer, more efficient drug development. By identifying disease mechanisms and stratifying patient populations, researchers can reduce uncertainty in clinical trials and improve therapeutic outcomes across diverse disease areas.

Unravel microbial interactions with network analysis. BioLizard shows how similarity, regression, and dynamic networks help detect keystone taxa, predict ecosystem effects, and turn complex microbiome data into actionable biological insights.

Uncover the plant microbiome with BioLizard. From amplicon and shotgun sequencing to meta-omics, these tools provide insights into microbial species, gene expression, and biochemical pathways shaping plant health and resilience.

Plant microbiomes play a vital role in plant health, growth, and resilience. From nutrient uptake to disease suppression, understanding these microbial communities enables sustainable agriculture, improved food quality, and potential benefits for human health. BioLizard provides expert analysis and tools for microbiome research.

At BioLizard’s VAIA Highway Session, experts explored how AI and multi-omics transform biomedical research. From single-cell analysis to precision immunology, the event highlighted cutting-edge tools, explainable AI, and strategies to turn complex data into actionable scientific insights.